Allogene Therapeutics, Inc. Financial Ratios — ALLO Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-54.66	-24.75	-32.52	-15.98	-36.36	-44.7	-43.24	-39.58
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	100	100	100	- -
EBITDA Margin (%)	- -	- -	- -	- -	-148.78	-205,923.72	-316,097.89	-1,108,377.27	- -
Operating Margin (%)	- -	- -	- -	- -	-157.94	-215,087.18	-331,044.21	-1,170,372.73	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-229,768.18
Pretax Margin (%)	- -	- -	- -	- -	-159.57	-218,214.1	-344,489.47	-1,168,850	- -
Profit Margin (%)	- -	- -	- -	- -	-159.57	-218,214.1	-344,489.47	-1,170,863.64	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	-159.57	-218,214.1	-344,489.47	-1,170,863.64	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	34	53	54	73	101	95	91	83
ST Debt	- -	- -	2	3	3	6	7	8	8
LT Debt	- -	34	51	51	70	95	88	83	75
Total Debt/EBITDA	- -	-0.18	-0.27	-0.21	-0.43	-0.31	-0.32	-0.37	-0.43
Net Debt/EBITDA	- -	0.48	0.89	0.73	1.02	0.19	0.28	0.31	0.27
Total Debt/EBIT	- -	-0.18	-0.26	-0.21	-0.41	-0.3	-0.3	-0.35	-0.4
Net Debt/EBIT	- -	0.48	0.87	0.71	0.96	0.18	0.26	0.29	0.25
EBITDA to Interest Expense	- -	-56.98	- -	- -	- -	- -	- -	-1,347.2	-181
EBITDA-CapEx/Interest Expense	- -	-57.94	- -	- -	- -	- -	- -	-1,351.03	-181.36
EBIT to Interest Expense	- -	-57.43	- -	- -	- -	- -	- -	-1,422.55	-192.5
Interest Expense	- -	3	- -	- -	- -	- -	- -	- -	1
Common Equity/Total Assets	- -	-27.32	-55.17	-52.63	-85.11	-150.3	-243	-331.62	-483.4
Long-Term Debt/Equity (%)	- -	4.9	8.16	4.71	7.56	14.26	17.25	19.72	25.65
Long-Term Debt/Capital (%)	- -	-19.47	-14.97	-8.58	-8.51	-8.39	-6.02	-4.82	-3.89
Long-Term Debt/Total Assets (%)	- -	4.45	7.15	4.14	6.65	11.58	13.74	15.17	18.04
Total Debt/Equity (%)	- -	4.9	8.43	4.98	7.9	15.16	18.57	21.5	28.46
Total Debt/Capital (%)	- -	-19.47	-15.46	-9.08	-8.9	-8.92	-6.48	-5.25	-4.32
Total Debt/Total Assets (%)	- -	4.45	7.39	4.38	6.96	12.31	14.8	16.54	20.02
Net Debt to Equity	- -	-13.15	-27.84	-16.98	-18.73	-9.28	-16.23	-17.82	-17.67
Net Debt/Capital (%)	- -	34.31	33.8	23.63	17.43	5.18	5.36	4.17	2.61
EBITDA	- -	-191	-197	-251	-170	-321	-300	-244	-195
EBITDA-CapEx	- -	-195	-248	-317	-191	-326	-302	-245	-195
Operating Income (Loss)	- -	-193	-202	-258	-180	-336	-314	-257	-207

Liquidity (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	15.59	16.04	8.78	9.55	9.63	12.1	8.23	7.7
Current Ratio	- -	15.89	16.46	8.96	9.84	9.84	12.38	8.54	7.93
Quick Ratio	- -	15.7	16.11	8.78	9.55	9.63	12.1	8.23	7.7
CFO/Avg Current Liab	- -	-3.03	-4.39	-1.81	-2.6	-4.34	-5.24	-5.52	-4.39
Common Equity/Total Assets	- -	-27.32	-55.17	-52.63	-85.11	-150.3	-243	-331.62	-483.4
Long-Term Debt/Equity (%)	- -	4.9	8.16	4.71	7.56	14.26	17.25	19.72	25.65
Long-Term Debt/Capital (%)	- -	-19.47	-14.97	-8.58	-8.51	-8.39	-6.02	-4.82	-3.89
Long-Term Debt/Total Assets (%)	- -	4.45	7.15	4.14	6.65	11.58	13.74	15.17	18.04
Total Debt/Equity (%)	- -	4.9	8.43	4.98	7.9	15.16	18.57	21.5	28.46
Total Debt/Capital (%)	- -	-19.47	-15.46	-9.08	-8.9	-8.92	-6.48	-5.25	-4.32
Total Debt/Total Assets (%)	- -	4.45	7.39	4.38	6.96	12.31	14.8	16.54	20.02
CFO/Total Liabilities	- -	-63.17	-154.71	-77.65	-147.11	-142.55	-182.03	-158.3	-120.98
CFO/CapEx	- -	-13.81	-2.7	-1.74	-8.62	-42.48	-156.82	-288.62	-386.65
Altman's Z-Score	- -	6.09	16.9	11.6	8.51	0.73	-1.91	-3.64	-6.29

Working Capital (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	780	2,626	3,038	2,026	900	504	415	302
- Cash & Cash Equivalents	- -	92	175	183	173	62	83	75	52
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	34	53	54	73	101	95	91	83
Enterprise Value	- -	355	2,148	2,264	1,642	484	150	213	135
Total Capital	- -	-177	-343	-592	-821	-1,134	-1,467	-1,729	-1,927
Total Debt/Capital (%)	- -	-19.47	-15.46	-9.08	-8.9	-8.92	-6.48	-5.25	-4.32
Total Debt / EV	- -	0.1	0.02	0.02	0.04	0.21	0.63	0.43	0.62
EV/Sales	- -	- -	- -	- -	14.39	3,103.84	1,580.79	9,692.23	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	780	2,626	3,038	2,026	900	504	415	302
Diluted Enterprise Value	- -	722	2,503	2,909	1,926	940	516	430	334
EV per Share	- -	12.25	21.26	18.81	12.09	3.38	0.96	1.09	0.61
TTM Sales	- -	- -	- -	- -	114	- -	- -	- -	- -
TTM EBITDA	- -	-191	-197	-251	-170	-321	-300	-244	-195
TTM Operating Income	- -	-193	-202	-258	-180	-336	-314	-257	-207
TTM Cash Flow to Firm	- -	-41	-137	-115	-185	-221	-238	-200	-148
TTM Free Cash Flow to Firm	- -	-38	-87	-49	-163	-215	-236	-199	-148

Multiples (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-18.82	-30.33	-61.83	-12.4	-4.18	-2.13	-2.08	-2.03
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	355	2,148	2,264	1,642	484	150	213	135
Low Price	- -	21.67	24.6	17.43	12.9	5.56	2.23	1.78	0.86
EV/Sales	- -	- -	- -	- -	14.39	3,103.84	1,580.79	9,692.23	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-3.64	-15.45	-12.41	-19.25	-4.44	-2.28	-2.31	-1.65
Price/Earnings High	- -	-4.87	-18.5	-20.93	-29.19	-7.35	-4.05	-4.37	-4.37
Price/Earnings Low	- -	-2.97	-13.47	-6.63	-9.62	-2.34	-1.07	-1.35	-1
Price/Book Value	- -	-3.69	-6.63	-4.7	-2.27	-0.73	-0.32	-0.23	-0.15
Price/Book Value Average	- -	-3.64	-7.2	-6.08	-3.92	-1.22	-0.48	-0.33	-0.16
Price/Book Value High	- -	-4.87	-8.63	-10.25	-5.94	-2.03	-0.85	-0.62	-0.41
Price/Book Value Low	- -	-2.97	-6.28	-3.25	-1.96	-0.64	-0.22	-0.19	-0.09
Price/Tangible Book Value	- -	1.11	4.18	2.81	2.19	1.35	0.98	0.98	1.03
Price/Tangible Book Value Average	- -	1.09	4.53	3.64	3.79	2.27	1.46	1.41	1.07
Price/Tangible Book Value High	- -	1.47	5.43	6.13	5.74	3.75	2.59	2.67	2.85
Price/Tangible Book Value Low	- -	0.89	3.95	1.94	1.89	1.19	0.68	0.82	0.65
Price/Sales	- -	- -	- -	- -	17.76	5,771.77	5,302.64	18,861.32	- -
Price/Sales Average	- -	- -	- -	- -	30.72	9,684.48	7,848.01	27,016.08	- -
Price/Sales High	- -	- -	- -	- -	46.57	16,049	13,942.15	51,182.36	- -
Price/Sales Low	- -	- -	- -	- -	15.36	5,101.91	3,683.77	15,762.04	- -
Price/Cash Flow	- -	-17.46	-19.12	-26.4	-10.96	-4.08	-2.12	-2.07	-2.03
Price/Cash Flow Average	- -	-17.22	-20.76	-34.12	-18.96	-6.85	-3.14	-2.97	-2.11
Price/Cash Flow High	- -	-23.05	-24.87	-57.52	-28.75	-11.35	-5.57	-5.62	-5.59
Price/Cash Flow Low	- -	-14.05	-18.1	-18.23	-9.48	-3.61	-1.47	-1.73	-1.27
Price/Free Cash Flow Average	- -	-18.57	-32.94	-79.92	-21.45	-7.02	-3.16	-2.98	-2.11
Price/Free Cash Flow High	- -	-24.85	-39.46	-134.74	-32.52	-11.63	-5.61	-5.64	-5.6
Price/Free Cash Flow Low	- -	-15.15	-28.72	-42.7	-10.72	-3.7	-1.48	-1.74	-1.28
EV/Sales Average	- -	- -	- -	- -	29.84	9,935.89	7,973.97	27,722.35	- -
EV/Sales High	- -	- -	- -	- -	45.69	16,300.41	14,068.11	51,888.63	- -
EV/Sales Low	- -	- -	- -	- -	14.48	5,353.32	3,809.72	16,468.31	- -
EV/EBITDA Average	- -	-3.72	-13.86	-15.15	-20.06	-4.83	-2.52	-2.5	-1.78
EV/EBITDA High	- -	-5.08	-16.72	-25.9	-30.71	-7.92	-4.45	-4.68	-4.45
EV/EBITDA Low	- -	-2.98	-12	-7.85	-9.73	-2.6	-1.21	-1.49	-1.14
EV/EBIT Average	- -	-3.69	-13.51	-14.71	-18.89	-4.62	-2.41	-2.37	-1.67
EV/EBIT High	- -	-5.04	-16.31	-25.13	-28.93	-7.58	-4.25	-4.43	-4.18
EV/EBIT Low	- -	-2.95	-11.7	-7.62	-9.17	-2.49	-1.15	-1.41	-1.07
Last Price	- -	26.93	25.98	25.24	14.92	6.29	3.21	2.13	1.37
High Price	- -	35.55	33.8	55	39.12	17.49	8.44	5.78	3.78
Enterprise Value Average	- -	711	2,730	3,798	3,405	1,550	758	610	346
Enterprise Value High	- -	971	3,294	6,491	5,213	2,543	1,336	1,142	866
Enterprise Value Low	- -	569	2,364	1,968	1,652	835	362	362	222

Shares Outstanding	114	121	124	140	143	144	169	212	229
Diluted Weighted Avg Shares	- -	29	101	120	136	143	157	195	221
Basic Weighted Avg Shares	- -	29	101	120	136	143	157	195	221
Revenue per Share	- -	- -	- -	- -	0.84	- -	- -	- -	- -
EBITDA per Share	- -	-6.61	-1.95	-2.08	-1.25	-2.24	-1.91	-1.25	-0.88
Operating Income per Share	- -	-6.66	-2	-2.15	-1.33	-2.34	-2	-1.32	-0.94
Basic EPS, GAAP	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Basic EPS from Cont Ops	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Diluted EPS, GAAP	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Diluted EPS from Cont Ops	- -	-7.31	-1.83	-2.63	-1.34	-2.38	-2.09	-1.32	-0.87
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-1.54	-1.36	-0.96	-1.36	-1.54	-1.51	-1.03	-0.68
Free Cash Flow per Basic Share	- -	-1.65	-1.86	-1.5	-1.52	-1.58	-1.52	-1.03	-0.68
Cash & Equivalents per Share	- -	15.87	5.25	6.88	3.37	3.61	2.86	1.5	1.13
Book Value per Share	- -	-7.3	-3.92	-5.37	-6.59	-8.63	-9.95	-9.34	-9.11
Tangible Book Value per Share	- -	24.26	6.22	8.97	6.81	4.66	3.26	2.17	1.33

Allogene Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)